在Klebsiella pneumoniae的组合疗法下快速适应进化
Camila Maurmann de Souza1,2, Amy Lee3, Osmel Fleitas Martínez1
1Centro de Análises Proteômicas e Bioquímicas, Programa de Pós-Graduação Em Ciências Genômicas e Biotecnologia, Universidade Católica de Brasília, Brasília 71966-700, Brazil.
ACS infectious diseases
|February 10, 2026
概括
克莱布西拉肺炎迅速发展出对阿米卡辛和聚米辛B组合疗法的高水平耐药性. 这项研究揭示了导致耐药性和交叉耐药性的基因突变,强调了需要新的抗生素策略.
科学领域:
- 微生物学 微生物学
- 进化生物学 进化生物学
- 抗微生物耐药性 抗微生物耐药性
背景情况:
- 由于高死亡率和日益增长的抗生素耐药性,Klebsiella pneumoniae是一个全球性健康威胁.
- 组合抗生素治疗是对抗耐药病原体的策略,但这些疗法下的耐药性演变不明.
研究的目的:
- 为了研究Klebsiella pneumoniae中耐药性的体外演变,暴露于阿米卡辛和B.多素的组合.
- 识别与快速抗药性发展相关的遗传和转录基因变化.
主要方法:
- 一个体外进化实验,使用一种产生KPC的Klebsiella pneumoniae分离物.
- 在45个通道中暴露于亚抑制度的阿米卡辛和聚米辛B.
- 全基因组测序和转录组学分析.
- 确定最小抑制度 (MIC) 和评估交叉耐药性.
主要成果:
- 快速演变的稳定,高水平的耐药性阿米卡辛和多素B,与MICs显著超过断点.
- 在包括lapB,phoP,rho,smbA,mlaA和asmA在内的基因突变的识别.
- 运和aphA的上调,以及包膜和流出基因的下调.
- 观察到对胆固醇和抗微生物的交叉耐药性.
结论:
- 克莱布西拉肺炎可以快速发展出稳定,高水平的抗性,对阿米卡-多胺乙组合疗法.
- 鉴定到的遗传和转录基因变异为抵抗机制提供了洞察力.
- 研究结果强调,迫切需要更好地了解组合疗法下的耐药性演变以及开发新型抗菌战略.
相关概念视频
02:55The Evidence for Evolution
48.4K
Genetic variations accumulating within populations over generations give rise to biological evolution. Evolutionary changes can result in the formation of novel varieties and entire new species. These changes are responsible for the diverse forms of life inhabiting the planet. The evidence for evolution suggests that all living organisms descended from common ancestors.
48.4K
02:50Combination Therapies and Personalized Medicine
6.2K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.2K
01:54Convergent Evolution
33.1K
Evolution shapes the features of organisms over time, ensuring that they are suited for the environments in which they live. Sometimes, selection pressure leads to the rise of similar but unrelated adaptations in organisms with no recent common ancestors, a process known as convergent evolution.
33.1K
01:30Pneumonia I: Introduction
925
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
925
01:29Pneumonia II: Pathophysiology
3.0K
The pathophysiology of pneumonia involves the following steps:
3.0K
01:24Eukaryotic Evolution
42.3K
The endosymbiont theory is the most widely accepted theory of eukaryotic evolution; however, its progression is still somewhat debated. According to the nucleus-first hypothesis, the ancestral prokaryote first evolved a membrane to enclose DNA and form the nucleus. Conversely, the mitochondria-first hypothesis suggests that the nucleus was formed after endosymbiosis of mitochondria.
Contrary to the endosymbiont theory, the eukaryote-first hypothesis proposes that the simpler prokaryotic and...
Contrary to the endosymbiont theory, the eukaryote-first hypothesis proposes that the simpler prokaryotic and...
42.3K